Sage Therapeutics on PRIME, Partnerships and Pricing For Its PPD First

 
• By Francesca Bruce

Sage Therapeutics is on track to deliver the first ever drug to be indicated for postpartum depression. The company discusses plans for launch and whether or not it wants to partner.

More from Neurological

More from Therapy Areas